Advisers, Industry Push Linking Mandatory Prescriber Opioid Training To DEA Registration

Members of two FDA advisory panels on Wednesday (May 4) proposed prescriber training be required as part of the risk mitigation plan for extended release and long-acting opioids, with several members saying mandatory training on responsible opioid prescribing practices be linked to the Drug Enforcement Administration registration. FDA noted that this would require a legislative change, but an agency official told the drug safety and the analgesic advisory committees that there is widespread agreement in government -- “from the president...